DOI QR코드

DOI QR Code

Role of dexmedetomidine as adjuvant in postoperative sciatic popliteal and adductor canal analgesia in trauma patients: a randomized controlled trial

  • Ahuja, Vanita (Department of Anesthesiology and Intensive Care, Government Medical College and Hospital) ;
  • Thapa, Deepak (Department of Anesthesiology and Intensive Care, Government Medical College and Hospital) ;
  • Chander, Anjuman (Department of Anesthesiology and Intensive Care, Government Medical College and Hospital) ;
  • Gombar, Satinder (Department of Anesthesiology and Intensive Care, Government Medical College and Hospital) ;
  • Gupta, Ravi (Department of Orthopedics, Government Medical College and Hospital) ;
  • Gupta, Sandeep (Department of Orthopedics, Government Medical College and Hospital)
  • Received : 2019.04.29
  • Accepted : 2019.12.19
  • Published : 2020.04.01

Abstract

Background: The effect of dexmedetomidine as an adjuvant in the adductor canal block (ACB) and sciatic popliteal block (SPB) on the postoperative tramadol-sparing effect following spinal anesthesia has not been evaluated. Methods: In this randomized, placebo-controlled study, ninety patients undergoing below knee trauma surgery were randomized to either the control group, using ropivacaine in the ACB + SPB; the block Dex group, using dexmedetomidine + ropivacaine in the ACB + SPB; or the systemic Dex group, using ropivacaine in the ACB + SPB + intravenous dexmedetomidine. The primary outcome was a comparison of postoperative cumulative tramadol patient-controlled analgesia (PCA) consumption at 48 hours. Secondary outcomes included time to first PCA bolus, pain score, neurological assessment, sedation score, and adverse effects at 0, 5, 10, 15, and 60 minutes, as well as 4, 6, 12, 18, 24, 30, 36, 42, and 48 hours after the block. Results: The mean ± standard deviation of cumulative tramadol consumption at 48 hours was 64.83 ± 51.17 mg in the control group and 41.33 ± 38.57 mg in the block Dex group (P = 0.008), using Mann-Whitney U-test. Time to first tramadol PCA bolus was earlier in the control group versus the block Dex group (P = 0.04). Other secondary outcomes were comparable. Conclusions: Postoperative tramadol consumption was reduced at 48 hours in patients receiving perineural or systemic dexmedetomidine with ACB and SPB in below knee trauma surgery.

Keywords

References

  1. Jones J Jr, Southerland W, Catalani B. The importance of optimizing acute pain in the orthopedic trauma patient. Orthop Clin North Am 2017; 48: 445-65. https://doi.org/10.1016/j.ocl.2017.06.003
  2. Wiznia DH, Zaki T, Leslie MP, Halaszynski TM. Complexities of perioperative pain management in orthopedic trauma. Curr Pain Headache Rep 2018; 22: 58. https://doi.org/10.1007/s11916-018-0713-5
  3. Gadsden J, Warlick A. Regional anesthesia for the trauma patient: improving patient outcomes. Local Reg Anesth 2015; 8: 45-55. https://doi.org/10.2147/LRA.S55322
  4. Christie IW, McCabe S. Major complications of epidural analgesia after surgery: results of a six-year survey. Anaesthesia 2007; 62: 335-41. https://doi.org/10.1111/j.1365-2044.2007.04992.x
  5. Sites BD, Antonakakis JG. Ultrasound guidance in regional anesthesia: state of the art review through challenging clinical scenarios. Local Reg Anesth 2009; 2: 1-14. https://doi.org/10.2147/LRA.S3444
  6. Davies AF, Segar EP, Murdoch J, Wright DE, Wilson IH. Epidural infusion or combined femoral and sciatic nerve blocks as perioperative analgesia for knee arthroplasty. Br J Anaesth 2004; 93: 368-74. https://doi.org/10.1093/bja/aeh224
  7. Lollo L, Bhananker S, Stogicza A. Postoperative sciatic and femoral or saphenous nerve blockade for lower extremity surgery in anesthetized adults. Int J Crit Illn Inj Sci 2015; 5: 232-6. https://doi.org/10.4103/2229-5151.170846
  8. YaDeau JT, Paroli L, Fields KG, Kahn RL, LaSala VR, Jules-Elysee KM, et al. Addition of dexamethasone and buprenorphine to bupivacaine sciatic nerve block: a randomized controlled trial. Reg Anesth Pain Med 2015; 40: 321-9. https://doi.org/10.1097/AAP.0000000000000254
  9. Jeon YH. The use of adjuvants to local anesthetics: benefit and risk. Korean J Pain 2018; 31: 233-34. https://doi.org/10.3344/kjp.2018.31.4.233
  10. Kauppila T, Kemppainen P, Tanila H, Pertovaara A. Effect of systemic medetomidine, an alpha 2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology 1991; 74: 3-8. https://doi.org/10.1097/00000542-199101000-00002
  11. Thapa D, Ahuja V, Pandey K, Gombar S, Gupta R. Evaluation of analgesic efficacy of dexmedetomidine as adjuvant with ropivacaine in ultrasound-guided adductor canal block in patients following anterior cruciate ligament reconstruction surgeries. Br J Pain 2019; 13: 91-8. https://doi.org/10.1177/2049463718796865
  12. Gaumann D, Forster A, Griessen M, Habre W, Poinsot O, Della Santa D. Comparison between clonidine and epinephrine admixture to lidocaine in brachial plexus block. Anesth Analg 1992; 75: 69-74.
  13. Miaskowski C, Crews J, Ready LB, Paul SM, Ginsberg B. Anesthesia-based pain services improve the quality of postoperative pain management. Pain 1999; 80: 23-9. https://doi.org/10.1016/S0304-3959(98)00192-4
  14. Carney J, McDonnell JG, Ochana A, Bhinder R, Laffey JG. The transversus abdominis plane block provides effective postoperative analgesia in patients undergoing total abdominal hysterectomy. Anesth Analg 2008; 107: 2056-60. https://doi.org/10.1213/ane.0b013e3181871313
  15. Sim JH, Yu HJ, Kim ST. The effects of different loading doses of dexmedetomidine on sedation. Korean J Anesthesiol 2014; 67: 8-12. https://doi.org/10.4097/kjae.2014.67.1.8
  16. Fukuda TY, Fingerhut D, Moreira VC, Camarini PM, Scodeller NF, Duarte A Jr, et al. Open kinetic chain exercises in a restricted range of motion after anterior cruciate ligament reconstruction: a randomized controlled clinical trial. Am J Sports Med 2013; 41: 788-94. https://doi.org/10.1177/0363546513476482
  17. Holdgate A, Asha S, Craig J, Thompson J. Comparison of a verbal numeric rating scale with the visual analogue scale for the measurement of acute pain. Emerg Med (Fremantle) 2003; 15: 441-6. https://doi.org/10.1046/j.1442-2026.2003.00499.x
  18. Trein TA, Floriano BP, Wagatsuma JT, Ferreira JZ, da Silva GL, Dos Santos PS, et al. Effects of dexmedetomidine combined with ropivacaine on sciatic and femoral nerve blockade in dogs. Vet Anaesth Analg 2017; 44: 144-53. https://doi.org/10.1111/vaa.12399
  19. Brummett CM, Hong EK, Janda AM, Amodeo FS, Lydic R. Perineural dexmedetomidine added to ropivacaine for sciatic nerve block in rats prolongs the duration of analgesia by blocking the hyperpolarization-activated cation current. Anesthesiology 2011; 115: 836-43. https://doi.org/10.1097/ALN.0b013e318221fcc9
  20. Lin YN, Li Q, Yang RM, Mao ZX, Liu JC. Addition of dexmedetomidine to ropivacaine improves cervical plexus block. Acta Anaesthesiol Taiwan 2013; 51: 63-6. https://doi.org/10.1016/j.aat.2013.06.001
  21. Abdallah FW, Abrishami A, Brull R. The facilitatory effects of intravenous dexmedetomidine on the duration of spinal anesthesia: a systematic review and meta-analysis. Anesth Analg 2013; 117: 271-8. https://doi.org/10.1213/ANE.0b013e318290c566
  22. Andersen JH, Grevstad U, Siegel H, Dahl JB, Mathiesen O, Jæger P. Does dexmedetomidine have a perineural mechanism of action when used as an adjuvant to ropivacaine?: a paired, blinded, randomized trial in healthy volunteers. Anesthesiology 2017; 126: 66-73. https://doi.org/10.1097/ALN.0000000000001429
  23. Fritsch G, Danninger T, Allerberger K, Tsodikov A, Felder TK, Kapeller M, et al. Dexmedetomidine added to ropivacaine extends the duration of interscalene brachial plexus blocks for elective shoulder surgery when compared with ropivacaine alone: a single-center, prospective, triple-blind, randomized controlled trial. Reg Anesth Pain Med 2014; 39: 37-47. https://doi.org/10.1097/AAP.0000000000000033
  24. Yoshitomi T, Kohjitani A, Maeda S, Higuchi H, Shimada M, Miyawaki T. Dexmedetomidine enhances the local anesthetic action of lidocaine via an alpha-2A adrenoceptor. Anesth Analg 2008; 107: 96-101. https://doi.org/10.1213/ane.0b013e318176be73
  25. Nie Y, Liu Y, Luo Q, Huang S. Effect of dexmedetomidine combined with sufentanil for post-caesarean section intravenous analgesia: a randomised, placebo-controlled study. Eur J Anaesthesiol 2014; 31: 197-203.
  26. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59: 263-8. https://doi.org/10.2165/00003495-200059020-00012
  27. Karol MD, Maze M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Best Pract Res Clin Anaesthesiol 2000; 14: 261-9. https://doi.org/10.1053/bean.2000.0081
  28. Lee S, Kim BH, Lim K, Stalker D, Wisemandle W, Shin SG, et al. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. J Clin Pharm Ther 2012; 37: 698-703. https://doi.org/10.1111/j.1365-2710.2012.01357.x
  29. Peng K, Liu HY, Wu SR, Cheng H, Ji FH. Effects of combining dexmedetomidine and opioids for postoperative intravenous patient-controlled analgesia: a systematic review and metaanalysis. Clin J Pain 2015; 31: 1097-104. https://doi.org/10.1097/AJP.0000000000000219
  30. Sinha C, Kumar A, Kumari P, Singh AK, Sharma S, Kumar A, et al. Comparison of two doses of dexmedetomidine for supraclavicular brachial plexus block: a randomized controlled trial. Anesth Essays Res 2018; 12: 470-4. https://doi.org/10.4103/aer.AER_33_18
  31. Brummett CM, Padda AK, Amodeo FS, Welch KB, Lydic R. Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. Anesthesiology 2009; 111: 1111-9. https://doi.org/10.1097/aln.0b013e3181bbcc26
  32. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet 2017; 56: 893-913. https://doi.org/10.1007/s40262-017-0507-7
  33. Vorobeichik L, Brull R, Abdallah FW. Evidence basis for using perineural dexmedetomidine to enhance the quality of brachial plexus nerve blocks: a systematic review and metaanalysis of randomized controlled trials. Br J Anaesth 2017; 118: 167-81. https://doi.org/10.1093/bja/aew411
  34. Fisker AK, Iversen BN, Christensen S, Linde F, Nielsen KK, Borglum J, et al. Combined saphenous and sciatic catheters for analgesia after major ankle surgery: a double-blinded randomized controlled trial. Can J Anaesth 2015; 62: 875-82. https://doi.org/10.1007/s12630-015-0379-y
  35. Joe HB, Choo HS, Yoon JS, Oh SE, Cho JH, Park YU. Adductor canal block versus femoral nerve block combined with sciatic nerve block as an anesthetic technique for hindfoot and ankle surgery: a prospective, randomized noninferiority trial. Medicine (Baltimore) 2016; 95: e5758. https://doi.org/10.1097/md.0000000000005758
  36. Hu X, Li J, Zhou R, Wang Q, Xia F, Halaszynski T, et al. Dexmedetomidine added to local anesthetic mixture of lidocaine and ropivacaine enhances onset and prolongs duration of a popliteal approach to sciatic nerve blockade. Clin Ther 2017; 39: 89-97.e1. https://doi.org/10.1016/j.clinthera.2016.11.011
  37. Rivara FP, Mackenzie EJ, Jurkovich GJ, Nathens AB, Wang J, Scharfstein DO. Prevalence of pain in patients 1 year after major trauma. Arch Surg 2008; 143: 282-7. https://doi.org/10.1001/archsurg.2007.61
  38. Aaland MO, Marose K, Zhu TH. The lost to trauma patient follow-up: a system or patient problem. J Trauma Acute Care Surg 2012; 73: 1507-11. https://doi.org/10.1097/ta.0b013e31826fc928
  39. Goldsmith H, Curtis K, McCloughen A. Incidence, intensity, and impact of pain in recently discharged adult trauma patients: an exploratory study. J Trauma Nurs 2017; 24: 102-9. https://doi.org/10.1097/jtn.0000000000000273

Cited by

  1. Dexmedetomidine-induced hemodynamic instability in patients undergoing orthopedic upper limb surgery under brachial plexus block: a retrospective study vol.21, pp.1, 2020, https://doi.org/10.1186/s12871-021-01416-4
  2. The Effect of Intravenous Dexamethasone and Dexmedetomidine on Analgesia Duration of Supraclavicular Brachial Plexus Block: A Randomized, Four-Arm, Triple-Blinded, Placebo-Controlled Trial vol.11, pp.12, 2020, https://doi.org/10.3390/jpm11121267